camrelizumab
jiangsu hengrui pharmaceuticals
['cam ']
tert promoter mutation was the most frequent mutation but was not associated with outcome in our small series. pik3cam suggested pfs benefit from cmt while, on the contrary, dual pik3cam/tertm showed a trend towards shorter pfs with t. #asco23 #asco2023 #medtwitter #news 
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News